Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7270 p491
11 October 2003

This page
Reprint
Photocopy

   

PDF* 110K

Letters

  Concordance
  Remuneration
  Specials
  Artificial saliva
  Vaccines


Letters to the Editor

Concordance

Training in communication skills needed

From Mrs S. Steel, MRPharmS, and Miss A.-M. McCooey, MRPharmS

The activity of medication review has risen to prominence with the inclusion of specific targets in the National Service Framework for Older People. Medication reviews need to be evidence-based and patient-centred. Any change in treatment that is required should be achieved through the process of concordance, reaching an agreement with the patient that reflects their beliefs and wishes.

During a recent pharmacist-led medication review clinic in a general practitioner’s surgery we encountered some difficulty in putting concordance into practice.

An anxious, 75-year-old woman with asthma and heart failure presented at the clinic for a medication review. She took diazepam regularly for anxiety and expressed some confusion about her asthma treatment.

After reviewing her prescribing records it appeared to us that she had been under-ordering furosemide. To achieve concordance I (Anne-Marie McCooey) thought that an explanation about heart failure and its treatment was necessary and, recognising that she was extremely anxious, I attempted to introduce the topic gently. I asked her whether she had heard the term “heart failure” before going on to say that it was a silly term as it sounded rather drastic and that all it meant was that the heart perhaps was not working as efficiently as it once did. The furosemide, therefore, worked as a water tablet, reducing the fluid carried around the body and so reducing the pressure on the heart. It was, however, important that she take it regularly. The patient seemed to be happy with this explanation and the discussion returned to her confusion over her asthma therapy.

The following day the patient telephoned the surgery to tell me that she had been to see her GP that morning and told the GP that I had said that she had heart failure and that she was so worried about it, she had not slept the previous night. In discussing my experience with the GP, I was relieved to be reassured that I had not done anything untoward and that this woman’s anxiety is difficult to avoid.

Reflecting on this experience with colleagues, we identified specific learning needs about communicating with patients. However, finding development activities to improve skills in this area is proving difficult.

The National Prescribing Centre has identified clear competencies for nurse prescribers and for potential pharmacist prescribers that includes communication with patients, and training programmes are being designed to support achievement and maintenance of competency for new prescribers.

In stark contrast, many more health care professionals are likely to be involved in undertaking medication review and, although many of the competencies required are the same as those for prescribing, few training programmes exist.

Up to now, much education and training for pharmacists working in primary care has been focused on managing the rapid growth in prescribing spending rather than focusing on the clinical needs of individual patients and helping them get the most out of their medicines. If the NHS is serious about achieving medication review targets and putting concordance for taking medicines into practice, then a dramatic shift in the focus of continuing professional development activity is required for all health care professionals who communicate with patients about medicines.

Sharon Steel
Anne-Marie McCooey

Pharmaceutical Resource Network

Send your letter to The Editor

Next Topic (Remuneration)

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal